Debt-to-equity of Nuo Therapeutics, Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Nuo Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • Nuo Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -696%, a 686% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Nuo Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -696% -815% -686% 30 Sep 2025
Q2 2025 1378% +1250% +979% 30 Jun 2025
Q1 2025 206% +68% +50% 31 Mar 2025
Q4 2024 139% +40% +41% 31 Dec 2024
Q3 2024 119% +44% +59% 30 Sep 2024
Q2 2024 128% +81% +171% 30 Jun 2024
Q1 2024 138% +106% +338% 31 Mar 2024
Q4 2023 98% +68% +223% 31 Dec 2023
Q3 2023 75% +41% +124% 30 Sep 2023
Q2 2023 47% -7% -13% 30 Jun 2023
Q1 2023 31% -285% -90% 31 Mar 2023
Q4 2022 30% +1182% 31 Dec 2022
Q3 2022 33% +208% 30 Sep 2022
Q2 2022 54% +172% 30 Jun 2022
Q1 2022 317% +427% 31 Mar 2022
Q4 2021 -1152% -1047% -998% 31 Dec 2021
Q3 2021 -175% -68% -64% 30 Sep 2021
Q2 2021 -118% -11% -10% 30 Jun 2021
Q1 2021 -110% 0% -0.1% 31 Mar 2021
Q4 2020 -105% +16% +13% 31 Dec 2020
Q3 2020 -107% +43% +29% 30 Sep 2020
Q2 2020 -107% +84% +44% 30 Jun 2020
Q1 2020 -110% +173% +61% 31 Mar 2020
Q4 2019 -121% +294% +71% 31 Dec 2019
Q3 2019 -150% +665% +82% 30 Sep 2019
Q2 2019 -192% -250% -429% 30 Jun 2019
Q1 2019 -283% -320% -869% 31 Mar 2019
Q4 2018 -415% -438% -1877% 31 Dec 2018
Q3 2018 -815% -833% -4697% 30 Sep 2018
Q2 2018 58% +43% +276% 30 Jun 2018
Q1 2018 37% +23% +159% 31 Mar 2018
Q4 2017 23% 31 Dec 2017
Q3 2017 18% 30 Sep 2017
Q2 2017 15% 30 Jun 2017
Q1 2017 14% 31 Mar 2017
Q4 2015 1422% +1185% +501% 31 Dec 2015
Q3 2015 187% +9% +5.2% 30 Sep 2015
Q2 2015 220% +107% +96% 30 Jun 2015
Q1 2015 268% +207% +340% 31 Mar 2015
Q4 2014 236% +193% +448% 31 Dec 2014
Q3 2014 178% +147% +483% 30 Sep 2014
Q2 2014 112% +89% +390% 30 Jun 2014
Q1 2014 61% +41% +209% 31 Mar 2014
Q4 2013 43% -3% -5.9% 31 Dec 2013
Q3 2013 30% -32% -51% 30 Sep 2013
Q2 2013 23% -86% -79% 30 Jun 2013
Q1 2013 20% -339% -95% 31 Mar 2013
Q4 2012 46% 31 Dec 2012
Q3 2012 63% 30 Sep 2012
Q2 2012 108% 30 Jun 2012
Q1 2012 359% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.